ONX-0914 (PR-957)
To Order Contact us: stephen@expresspharmapulse.com
PR Immunohistochemistry control tissue array |
|||
| PM2-PR | TissueArray | each | EUR 78 |
|
Description: PR Immunohistochemistry control tissue array, including TNM and pathology grade of breast cancer, 11 cases/11 cores |
|||
Oprozomib (ONX-0912) |
|||
| A1934-10 | ApexBio | 10 mg | EUR 282 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-100 | ApexBio | 100 mg | EUR 895.2 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-25 | ApexBio | 25 mg | EUR 477.6 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-5 | ApexBio | 5 mg | EUR 205.2 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
Oprozomib (ONX-0912) |
|||
| A1934-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 255.6 |
|
Description: ONX-0912 (as known as oprozomib), discovered during a medicinal chemistry effort using tripeptide epoxyketones, is an orally bio-available and potent proteasome inhibitor that inhibits growth and induces apoptosis in bortezomib resistant multiple myeloma (MM) cells. |
|||
ACY-957 |
|||
| HY-104008 | MedChemExpress | 10mg | EUR 763.2 |
SMC1A (Ab-957) Antibody |
|||
| CSB-PA775738-100ul | Cusabio | 100ul | EUR 379.2 |
|
Description: A polyclonal antibody against SMC1A (Ab-957). Recognizes SMC1A (Ab-957) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
SMC1 (Ab-957) Antibody |
|||
| 21190-100ul | SAB | 100ul | EUR 302.4 |
SMC1 (Ab-957) Antibody |
|||
| 21190-50ul | SAB | 50ul | EUR 224.4 |
anti-SMC1 (Ab-957) |
|||
| LF-PA20461 | Abfrontier | 100 ul | EUR 400.8 |
|
Description: Rabbit polyclonal to SMC1 |
|||
SMC1A (Ab-957) Antibody |
|||
| CSB-PA775738- | Cusabio | each | EUR 402 |
|
Description: A polyclonal antibody against SMC1A (Ab-957). Recognizes SMC1A (Ab-957) from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:1000, IHC:1:50-1:200 |
|||
TIMP-2 Recombinant Protein |
|||
| 96-957 | ProSci | 0.05 mg | EUR 619.8 |
|
Description: TIMP metallopeptidase inhibitor 2 is also known as TIMP2, which belongs to the protease inhibitor I35 (TIMP) family. This family protein are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. The TIMP family encompasses four members (TIMP1, TIMP2, TIMP3, TIMP4), and they inhibit most MMPs by forming non-covalent binary complex. In addition to an inhibitory role against metalloproteinases, TIMP2 has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, TIMP-2 may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. |
|||
PR antibody |
|||
| 70R-36087 | Fitzgerald | 100 ug | EUR 392.4 |
|
Description: Rabbit polyclonal PR antibody |
|||
PR antibody |
|||
| 70R-36593 | Fitzgerald | 100 ug | EUR 392.4 |
|
Description: Rabbit polyclonal PR antibody |
|||
PR antibody |
|||
| 70R-13954 | Fitzgerald | 100 ug | EUR 386.4 |
|
Description: Affinity purified Rabbit polyclonal PR antibody |
|||
PR antibody |
|||
| 10R-1954 | Fitzgerald | 100 ul | EUR 418.8 |
|
Description: Mouse monoclonal PR antibody |
|||
PR-619 |
|||
| A8212-100 | ApexBio | 100 mg | EUR 448.8 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-25 | ApexBio | 25 mg | EUR 199.2 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-5 | ApexBio | 5 mg | EUR 115.2 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 170.4 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR-619 |
|||
| A8212-S | ApexBio | Evaluation Sample | EUR 97.2 |
|
Description: (2,6-diamino-5-thiocyanatopyridin-3-yl) thiocyanate, also designated as PR-619, is a broad-range reversible and cell-permeable inhibitor of deubiquitylating enzyme (DUB)[1][2][3], potently suppresses the activity of almost all cysteine protease DUBs[4]. |
|||
PR Antibody |
|||
| BF0581 | Affbiotech | 200ul | EUR 540 |
PR-619 |
|||
| HY-13814 | MedChemExpress | 50mg | EUR 439.2 |
PR Antibody |
|||
| F47596-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
PR Antibody |
|||
| F53580-0.1ML | NSJ Bioreagents | 0.1 ml | EUR 379 |
PR Antibody |
|||
| F47198-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
PR-619 |
|||
| 27714-1 | BPS Bioscience | 5 mg | EUR 220 |
|
Description: PR-619 is a non-selective, reversible inhibitor of deubiquitinases/deubiquitylases (DUBs) and ubiquitin-like isopeptidases. PR-619 inhibits many deubiquitinating enzymes in the 5-20 µM range. Additionally, PR-619 is cell permeable and treatment of cells results in the accumulation of both ubiquitin and sumo-conjugated proteins. |
|||
PR-619 |
|||
| 27714-2 | BPS Bioscience | 25 mg | EUR 535 |
|
Description: PR-619 is a non-selective, reversible inhibitor of deubiquitinases/deubiquitylases (DUBs) and ubiquitin-like isopeptidases. PR-619 inhibits many deubiquitinating enzymes in the 5-20 µM range. Additionally, PR-619 is cell permeable and treatment of cells results in the accumulation of both ubiquitin and sumo-conjugated proteins. |
|||
SMC1 (Ab-957) Conjugated Antibody |
|||
| C21190 | SAB | 100ul | EUR 476.4 |
Histone H1(HH1/957) Antibody |
|||
| BNCA0957-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Histone H1(HH1/957), APC conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCAP0957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCAP0957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC610957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC610957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNUM0957-50 | Biotium | 50uL | EUR 474 |
|
Description: Primary antibody against Histone H1(HH1/957), 1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCR0957-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Histone H1(HH1/957), RPE conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNUB0957-100 | Biotium | 100uL | EUR 250.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Concentration: 0.2mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNUB0957-500 | Biotium | 500uL | EUR 549.6 |
|
Description: Primary antibody against Histone H1(HH1/957), Concentration: 0.2mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC430957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC430957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC400957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC400957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC810957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC810957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC880957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC880957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC800957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC800957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCH0957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCH0957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCP0957-250 | Biotium | 250uL | EUR 459.6 |
|
Description: Primary antibody against Histone H1(HH1/957), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC050957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC050957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC680957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC680957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC700957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC700957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCB0957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNCB0957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC940957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC940957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC550957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC550957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC470957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC470957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC040957-100 | Biotium | 100uL | EUR 238.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Histone H1(HH1/957) Antibody |
|||
| BNC040957-500 | Biotium | 500uL | EUR 652.8 |
|
Description: Primary antibody against Histone H1(HH1/957), CF405S conjugate, Concentration: 0.1mg/mL |
|||